Medicare Enrolled

Dr. Ameet Patel, MD

Hematology & Oncology · St Petersburg, FL
Practice pattern: Mixed Practice — Diverse clinical practice across multiple procedure types
Consulting-driven
725 6TH AVE S STE 2200, St Petersburg, FL 33701
7278210017
In practice since 2016 (10 years)
NPI: 1548623903 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Patel from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Patel? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Patel

Dr. Ameet Patel is a hematology & oncology specialist in St Petersburg, FL, with 10 years of NPI registration. Based on federal Medicare data, Dr. Patel performed 36,814 Medicare services across 2,067 unique beneficiaries.

Between the years covered by Open Payments, Dr. Patel received a total of $3,527 from 14 pharmaceutical and/or device companies across 28 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in hematology & oncology. The majority of payments are for consulting, which typically reflects recognized clinical expertise sought by manufacturers. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Patel is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 10 years in practice ▲ Top 19% volume in FL $3,527 industry payments

Medicare Practice Summary

Medicare Utilization ↗
36,814
Medicare services
Top 19% in FL for hematology & oncology
2,067
Unique beneficiaries
$19
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~3,681 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Filgrastim injection (Zarxio) for white blood cells 10,680 $0 $2
Daratumumab injection (Darzalex) 6,841 $38 $137
Immune globulin infusion (Octagam) 3,970 $34 $252
Injection, rituximab-pvvr, biosimilar, (ruxience), 10 mg 2,860 $22 $194
Injection, decitabine, 1 mg 2,500 $1 $97
Dexamethasone injection (steroid) 2,072 $0 $1
Injection, granisetron hydrochloride, 100 mcg 1,860 $0 $25
Complete blood count (CBC) with differential 1,030 $8 $35
Office visit, established patient (30-39 min) 749 $96 $305
Comprehensive metabolic blood panel 679 $10 $62
Office visit, established patient (20-29 min) 412 $64 $205
Hospital follow-up visit, moderate complexity 304 $61 $210
Immunoglobulin level test 280 $9 $54
Administration of chemotherapy into vein, 1 hour or less 280 $92 $664
Injection of additional new drug or substance into vein 211 $11 $105
Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less 173 $47 $304
Administration of non-hormonal anti-neoplastic chemotherapy under skin or into muscle 162 $53 $205
Lactate dehydrogenase (enzyme) level 153 $6 $30
Infusion into a vein for therapy, prevention, or diagnosis, additional sequential infusion, 1 hour or less 153 $20 $144
Drug injection, under skin or into muscle 146 $11 $93
Infusion into a vein for therapy, prevention, or diagnosis, each additional hour 111 $15 $97
Unclassified drugs 108 $0 $48
Injection, diphenhydramine hcl, up to 50 mg 100 $1 $7
Ferritin level test (iron stores) 90 $13 $58
Magnesium level test 83 $7 $28
Hospital follow-up visit, high complexity 79 $91 $300
Infusion, normal saline solution , 1000 cc 64 $2 $19
Iron level test 59 $6 $26
Iron binding capacity test 59 $9 $34
Infusion into a vein for hydration, 31-60 minutes 55 $24 $249
Office visit, established patient, complex (40-54 min) 50 $134 $410
Initial hospital admission, high complexity 45 $134 $585
Hospital discharge management, 30+ min 44 $88 $305
Phosphate level test 38 $5 $23
Uric acid level test 38 $4 $24
Vitamin B-12 level test 32 $14 $74
Administration of additional new drug or substance into vein, 1 hour or less 31 $35 $248
Injection, alteplase recombinant, 1 mg 28 $70 $227
Administration of chemotherapy into vein, each additional hour 25 $21 $156
Injection of drug or substance into vein 24 $27 $240
Biopsy and aspiration of bone marrow sample for diagnosis 22 $131 $523
Folic acid level test 21 $14 $71
Infusion into a vein for hydration, each additional hour 19 $9 $73
Irrigation of implanted venous access drug delivery device 19 $17 $111
New patient office visit (45-59 min) 16 $127 $475
Declotting of central venous tube 14 $24 $117
Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes 13 $10 $156
Initial hospital admission, moderate complexity 12 $100 $400
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
12.3% high complexity
75.5% medium
12.1% routine

Industry Payment Transparency

Open Payments through 2024 ↗
$3,527
Total received (2022-2024)
Avg $1,176/year across 3 years
Bottom 46% in FL for hematology & oncology
14
Companies
28
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$2,821 (80.0%)
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$706 (20.0%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$1,793
2023
$1,524
2022
$210

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
ABBVIE INC.
$1,754
Janssen Scientific Affairs, LLC
$1,090
Pharmacyclics LLC, An AbbVie Company
$283
SANOFI-AVENTIS U.S. LLC
$142
Celgene Corporation
$40
Novartis Pharmaceuticals Corporation
$39
Janssen Biotech, Inc.
$30
Pharmacyclics LLC, an AbbVie Company
$28
SERVIER PHARMACEUTICALS LLC
$25
Amgen Inc.
$23
Daiichi Sankyo Inc.
$23
GlaxoSmithKline, LLC.
$18
Seagen Inc.
$18
GENZYME CORPORATION
$15
Top 3 companies account for 88.7% of total payments
Associated products mentioned in payments ›
ADCETRIS · DARZALEX · EPKINLY · Fabhalta · IMBRUVICA · Kyprolis · MOZOBIL · OJJAARA · Pomalyst · SARCLISA · SCEMBLIX · TECVAYLI · Tibsovo
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

The majority of payments (80%) are consulting fees, which typically reflect recognized clinical expertise sought by manufacturers.

Equivalent to $10 per 100 Medicare services performed
Looking for a hematology & oncology specialist in St Petersburg?
Compare hematology & oncology specialists in the St Petersburg area by procedure volume, costs, and industry payment transparency.
Browse hematology & oncology specialists nearby

Geographic Context

Hematology & oncology specialists within 10 mi
110
Per 100K population
11.5
County median income
$70,293
Nearest hospital
ORLANDO HEALTH BAYFRONT HOSPITAL
0.0 mi

Data Sources

Provider Registry NPPES Weekly updates
Medicare Enrollment PECOS Monthly updates
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not public N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →

Summary

Dr. Patel is a mixed practice specialist, with above-average Medicare volume (top 19% in FL), with consulting-driven industry engagement.

This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →

Frequently Asked Questions

Is Dr. Patel experienced with filgrastim injection (zarxio) for white blood cells?
Based on Medicare claims data, Dr. Patel performed 10,680 filgrastim injection (zarxio) for white blood cells services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Patel receive payments from pharmaceutical companies?
Yes. Dr. Patel received a total of $3,527 from 14 companies across 28 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Patel's costs compare to other hematology & oncology specialists in St Petersburg?
Dr. Patel's average Medicare payment per service is $19. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Patel) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →